Rachel Fisher
Nurse Practitioner · Marion, OHNPI 1285163071
Payments from drug & device makers
Across 190 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$974
- AstraZeneca$351
- Lilly USA, LLC$179
- Novo Nordisk$167
- Johnson & Johnson$138
- Abbott$116
- plus $988 from 27 others
What the payments were for
- Food & beverage$2,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $974 |
| AstraZeneca(2 entities) | 22 | $351 |
| Lilly USA, LLC | 10 | $179 |
| Novo Nordisk | 8 | $167 |
| Johnson & Johnson | 6 | $138 |
| Abbott | 6 | $116 |
| Nestle Healthcare Nutrition Inc. | 5 | $106 |
| Pfizer | 6 | $105 |
| Bayer | 6 | $100 |
| Boston Scientific | 3 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Amgen | 3 | $48 |
| GSK | 3 | $44 |
| Astellas Pharma US Inc | 3 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $10 |
| Corium, LLC | 1 | $8 |
How this compares
$2,912 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $62,020 |
| EliquisApixaban | 32 | $52,246 |
| FarxigaDapagliflozin Propanediol | 28 | $30,901 |
| TrulicityDulaglutide | 21 | $24,028 |
| JardianceEmpagliflozin | 14 | $22,862 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,840 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 27 | $5,932 |
| Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm | 15 | $4,485 |
| Atorvastatin Calcium | 244 | $2,259 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,761 |
| Levothyroxine Sodium | 164 | $1,534 |
| Losartan Potassium | 132 | $1,470 |
| Gabapentin | 88 | $1,425 |
| Metoprolol Succinate | 97 | $1,209 |
| Ventolin HfaAlbuterol Sulfate | 18 | $1,175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $167 | $62,02039 claims |
| PfizerEliquis | $105 | $52,24632 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $351 | $42,74246 claims |
| Lilly USA, LLCTrulicity | $179 | $24,02821 claims |
| Boehringer IngelheimJardiance | $21 | $22,86214 claims |
| GSKShingrix | $44 | $5,93227 claims |
| AbbVieSynthroid | $974 | $71019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Marion
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.